Cyclophosphamide Monohydrate is a nitrogen mustard alkylating agent utilized as a cytotoxic chemotherapy drug for the treatment of various conditions, including lymphomas, leukemias, myelomas, breast carcinoma,… Read more
Cyclophosphamide Monohydrate is a nitrogen mustard alkylating agent utilized as a cytotoxic chemotherapy drug for the treatment of various conditions, including lymphomas, leukemias, myelomas, breast carcinoma, ovarian adenocarcinoma, neuroblastoma, and retinoblastoma. Laboratories require high-quality reference standards of Cyclophosphamide Monohydrate, its pharmacopeial and non-pharmacopeial impurities, and stable isotope-labelled compounds to support rigorous analytical testing. These materials are essential for accurate impurity profiling, method validation, and ongoing quality control of drug substances. By using authentic standards and isotopically labelled internal standards, chemists can ensure precise identification and quantification of degradation products and process-related impurities throughout the pharmaceutical development and manufacturing lifecycle. Access to these specialized compounds facilitates compliance with regulatory guidelines and ensures the integrity of analytical data during stability studies and routine product release testing.